Polydeuterated Ambroxol Analogs for Stability and Prolonged Action
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing ambroxol formulations face challenges in stability and duration of action, limiting their therapeutic efficacy in treating conditions such as Gaucher's disease, Parkinson's disease, and other neurological disorders.
Innovation Solution
Development of polydeuterated analogs of ambroxol and related compounds, which exhibit increased stability and resistance to metabolism, enhancing their pharmacokinetic properties and therapeutic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If polydeuterated analogs of ambroxol are developed, then stability and duration of action are improved, but manufacturing complexity increases
Solution Approach 1:
The patent applies parameter changes by replacing hydrogen atoms with deuterium atoms in the ambroxol molecular structure. This isotopic substitution modifies the physical and chemical parameters of the compound, specifically enhancing metabolic stability and prolonging duration of action while maintaining the core therapeutic activity of the original molecule.
Solution Approach 2:
The invention creates composite molecular structures by combining the ambroxol core framework with deuterium-labeled substituents. These polydeuterated analogs represent composite materials at the molecular level, integrating stable deuterium-containing groups into the pharmacologically active scaffold to achieve enhanced therapeutic properties.
2Duration of action of moving object
If polydeuterated analogs of ambroxol are developed, then duration of action is prolonged, but production cost increases
Solution Approach 1:
The patent utilizes parameter changes through isotopic substitution, where deuterium replacement of hydrogen extends the duration of action by protecting against metabolic degradation. This fundamental parameter modification directly addresses the duration of action enhancement while the synthetic routes described provide a framework for managing production costs.
Solution Approach 2:
The invention employs copying strategies by synthesizing deuterated compounds from non-deuterated precursors using established organic synthesis methodologies. This approach allows replication of the successful ambroxol molecular scaffold with modifications that extend duration of action, leveraging existing synthetic knowledge to control production expenses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polydeuterated ambroxol analogs demonstrate improved stability and prolonged action, effectively treating respiratory diseases, lysosomal storage disorders, and neurological conditions, while potentially extending life expectancy and improving healthspan.
Implementation Method 1
polydeuterated analogs of ambroxol and related compounds... which exhibit increased stability and resistance to metabolism, enhancing their pharmacokinetic properties and therapeutic effects
Data Source
AI summary
The invention relates to polydeuterated analog forms of ambroxol and related compounds (including bromhexine and the ambroxol salt, ambroxol hydrochloride), compositions comprising same, and methods of preventing and/or treating various diseases and medical conditions involving the administration of polydeuterated analogs of ambroxol and related compounds.